Big Pharma: Glaxo Smith Klein Edition $3 Billion
We’ve discussed Avandia before in a blog post entitled “Drugs Causing Problems They’re Supposed to Treat.” the corruption in research reporting here, and further on the corruption and the “triumph of new age medicine” here. GlaxoSmithKline to pay a record
